The FusionPlex Sarcoma v2 panel is a targeted next-generation sequencing (NGS) research product that expands on our FusionPlex Sarcoma panel. The updated design covers key fusions and variants in 63 genes relevant in sarcomas. FusionPlex uses RNA instead of DNA as input material, which allows for more accurate and more cost-effective fusion detection than DNA-based hybrid capture techniques. FusionPlex places gene-specific primers near known fusion breakpoints to identify RNA abnormalities with a single primer. Because FusionPlex can identify known and novel alterations with a limited number of primers, it can detect fusions more efficiently and accurately than DNA-based approaches